These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8811201)

  • 1. Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.
    de Oliveira CB; Stevenson D; LaBree L; McDonnell PJ; Trousdale MD
    Antiviral Res; 1996 Jul; 31(3):165-72. PubMed ID: 8811201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model.
    Romanowski EG; Yates KA; Gordon YJ
    Antiviral Res; 2001 Dec; 52(3):275-80. PubMed ID: 11675144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
    Gordon YJ; Romanowski EG; Araullo-Cruz T
    Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
    Kaneko H; Mori S; Suzuki O; Iida T; Shigeta S; Abe M; Ohno S; Aoki K; Suzutani T
    Antiviral Res; 2004 Jan; 61(1):63-6. PubMed ID: 14670595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model.
    Romanowski EG; Gordon YJ; Araullo-Cruz T; Yates KA; Kinchington PR
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1812-5. PubMed ID: 11431446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
    Romanowski EG; Araullo-Cruz T; Gordon YJ
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
    Romanowski EG; Gordon YJ
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):460-3. PubMed ID: 10670476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
    Romanowski EG; Gordon YJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections.
    Romanowski EG; Yates KA; Gordon YJ
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5295-9. PubMed ID: 19516011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir.
    Gordon YJ; Araullo-Cruz TP; Johnson YF; Romanowski EG; Kinchington PR
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2774-8. PubMed ID: 8977495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model.
    Gordon YJ; Romanowski E; Araullo-Cruz T; De Clercq E
    Cornea; 1992 Nov; 11(6):529-33. PubMed ID: 1334824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
    Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro.
    Gordon YJ; Romanowski E; Araullo-Cruz T; Seaberg L; Erzurum S; Tolman R; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):11-6. PubMed ID: 1776874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
    Clement C; Capriotti JA; Kumar M; Hobden JA; Foster TP; Bhattacharjee PS; Thompson HW; Mahmud R; Liang B; Hill JM
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):339-44. PubMed ID: 20702820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ocular model of Adenovirus type 5 infection in the rabbit.
    De Hauwere B; Lutz A; Maudgal PC; Neyts J; de Clercq E
    Bull Soc Belge Ophtalmol; 1995; 259():33-42. PubMed ID: 8936772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of adenovirus-induced eye disease in the rabbit model.
    Trousdale MD; Nóbrega R; Wood RL; Stevenson D; dos Santos PM; Klein D; McDonnell PJ
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2740-8. PubMed ID: 7499096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
    Tollefson AE; Spencer JF; Ying B; Buller RM; Wold WS; Toth K
    Antiviral Res; 2014 Dec; 112():38-46. PubMed ID: 25453340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiviral effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine on adenovirus].
    Nakajima H; Goto M; Shimada Y; Nagamoto Y; Ishiko H; Inagawa W; Itoh N; Uchio E; Ohno S; Aoki K
    Nippon Ganka Gakkai Zasshi; 2000 Feb; 104(2):77-81. PubMed ID: 10714154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir.
    Kinchington PR; Araullo-Cruz T; Vergnes JP; Yates K; Gordon YJ
    Antiviral Res; 2002 Oct; 56(1):73-84. PubMed ID: 12323401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.